Early molecular changes in Huntington’s appear to be largely due to the loss of normal huntingtin protein function, a new study found.| Huntington's Disease News
Early care planning helps Huntington's patients and families cope as the disease progresses, speakers at the HDSA annual convention said.| Huntington's Disease News
At the HDSA 2025 convention, social workers reported that building community among Huntington's patients can help combat disease stigma.| Huntington's Disease News
Columnist Tanita Allen shares how mindfulness and meditation practices offer a sense of stability amid the unpredictability of Huntington's.| Huntington's Disease News
Columnist Carlos Briceño is motivated to advocate for his wife by writing a letter after a disappointing exchange with a service provider.| Huntington's Disease News
Columnist Tanita Allen focuses on the small wins and the proper mindset as part of making progress over the setbacks of Huntington's disease.| Huntington's Disease News
A genetic disease like Huntington's affects the entire family tree, not just those who inherit the condition, says columnist Carlos Briceño.| Huntington's Disease News
Columnist Carlos Briceño says telehealth has made the process of seeking mental healthcare easier and more comfortable for his wife, Jill.| Huntington's Disease News
US neurologists are optimistic about the potential for a new Huntington's disease treatment - preferably a gene therapy - per a market survey.| Huntington's Disease News
Columnist Carlos Briceño sympathizes with his wife's stress as she handles the TSA PreCheck application process with her Huntington's.| Huntington's Disease News
Columnist Carlos Briceño finds an online resource to help Huntington's patients answer the question "What is chorea?"| Huntington's Disease News
Ingrezza's effects on Huntington's-associated chorea appear stronger over time, according to an analysis of the Phase 3 KINECT-HD trial.| Huntington's Disease News
Ingrezza has been associated with sustained reductions in Huntington's chorea, regardless of concurrent antipsychotic medication use.| Huntington's Disease News
Columnist Carlos Briceño and his wife delay talking about any HD symptoms they notice, lest they fall victim to the frequency illusion.| Huntington's Disease News
Society wants us to act heroic, but that's not always possible, opines columnist Carlos Briceño, who recommends embracing vulnerability.| Huntington's Disease News
Managing anxiety can be difficult, regardless of whether or not it's a symptom of Huntington's disease, says columnist Carlos Briceño.| Huntington's Disease News
Carlos Briceño welcomes you to his new column, "A Family Tradition," where he discusses his family's journey with Huntington's disease.| Huntington's Disease News
Columnist Carlos Briceño is devastated to realize how much the symptoms of Huntington's are beginning to affect his wife, Jill.| Huntington's Disease News
The outlook for the Huntington's community has never been brighter, Louise Vetter, president and CEO of the HDSA, said at the organization's annual convention.| Huntington's Disease News
Different types of genetic tests for Huntington's are available, depending on the time of testing and whether the individual is symptomatic.| Huntington's Disease News
Columnist Carlos Briceño says it's not Huntington's that defines his wife, Jill, but rather her fighting spirit and fierce attitude.| Huntington's Disease News
Huntington’s disease is diagnosed definitively through genetic testing, but initial tests are usually taken to find out a potential family history and any evidence of symptoms.| Huntington's Disease News
Two proteins, neurofilament light chain and phosphorylated tau, can serve as markers of Huntington's disease progression, a study found.| Huntington's Disease News
One of the main Huntington's disease Causes is a mutation in a gene called huntingtin (HTT). Learn more about it.| Huntington's Disease News
An oral granule formulation of Ingrezza, called Ingrezza Sprinkle, has been granted FDA approval for treating Huntington's-associated chorea.| Huntington's Disease News
Ingrezza is an oral medication approved in the U.S. for chorea, or the involuntary, jerky movements that characterize Huntington’s disease.| Huntington's Disease News
Columnist Carlos Briceño's wife, Jill, has always been unstoppable and fiercely independent. One day, Huntington's will change that.| Huntington's Disease News
Researchers suggest people carrying a Huntington's-causing mutation reduce sedentary behavior to delay the occurrence of motor symptoms.| Huntington's Disease News
Education levels, alcohol intake, not smoking, and a good weight before symptoms manifest may affect Huntington's disease progression.| Huntington's Disease News
Levels of GFAP in cerebrospinal fluid (CSF) may be a marker of Huntington’s disease progression, a study found.| Huntington's Disease News
Ingrezza Sprinkle is a formulation of oral Ingrezza that's designed to be easier to swallow, with capsule's granules sprinkled on soft foods.| Huntington's Disease News